Detailed Narrative
Q4 and Full Year FY26 Financial Performance
Vinati Organics reported a robust Q4 FY26, with consolidated net income increasing by 16% QoQ to INR624 crores and EBITDA growing 15% QoQ to INR191 crores. Consolidated PAT for the quarter saw a strong 23% QoQ growth, reaching INR123 crores. For the full fiscal year FY26, consolidated net income remained stable at INR2,280 crores, while EBITDA grew 13% to INR707 crores from INR625 crores in FY25. PAT for FY26 increased by 9% to INR444 crores compared to INR405 crores in the previous year, demonstrating resilient performance despite market challenges🌐.
Segmental Performance and FY27 Outlook
The company's ATBS segment maintained a robust global market share, with capacity expansion successfully completed, and expects 15% volume growth for the next three years. The butyl phenols segment delivered steady performance in FY26 and anticipates moderate growth in FY27. IB and HP-MTBE are projected to achieve double-digit growth in FY27. The customized products segment recorded strong 10% YoY growth, while the antioxidants business grew 15% in FY26 and is expected to maintain strong momentum in FY27. Overall, Vinati Organics targets approximately 15% volume growth at the company level for FY27.
Capital Expenditure and Future Growth Initiatives
In FY26, Vinati Organics incurred INR270 crores in capex, primarily for VOPL, capacity expansion, and new product development. For FY27, the company has earmarked INR200-250 crores for continued investment in capacity expansion, innovation, and operational efficiency. The company plans to invest INR250-300 crores annually for the next 3-5 years, focusing on value-added products from existing lines for industries like fragrance, personal care, food additives, and plastics. The ATBS capacity expansion, involving two phases, cost between INR250-300 crores.
VOPL Subsidiary Update and Re-engineering
The 100% subsidiary, VOPL, contributed minimally with only INR10 crores in sales in FY26. The new products at VOPL faced initial teething troubles and require process re-engineering, which is expected to be completed by September 2026. Production is anticipated to commence from October 2026, with revenue contribution expected from Q3 FY27 onwards. Management projects VOPL to generate INR100-120 crores in revenue in FY27 after the re-engineering is done, with the MEHQ/Guaiacol project being a primary contributor to this target.
Raw Material Stability and Market Headwinds
The company experienced a 20% volume decline in IBB in FY25 due to raw material unavailability linked to the Iran war, but these issues have since been resolved, and production is back on track. While the sector has faced cyclicality, overstocking, and fluctuations in raw material and logistics costs, Vinati Organics states it has managed these headwinds effectively. The company has maintained its margins by passing on price increases and decreases, ensuring stability in its operations.
Antioxidants Business and Anti-Dumping Duty (ADD)
The antioxidants business delivered 15% revenue growth in FY26, but continues to face challenges from aggressive undercutting and selling by Chinese competitors. The company's application for Anti-Dumping Duty (ADD) on antioxidants was initially rejected. Vinati Organics has reapplied, citing a strong case, but expects a decision to take another 6 to 9 months. This ongoing situation highlights the competitive pressure in the segment, which management aims to address through regulatory support.